Abstract: A polymer blend comprising polyamide, polypropylene (PP) and at least one of poly (lactic acid) (PLA) and a multi-phase compatibilizer comprising PA11-co-PP-maleic anhydride (MA). The polymer blend can be reinforced with hybrid fillers including biocarbon, glass fiber, carbon fiber and nano-clay to create composites useful in the creation of products of manufacture such as auto parts.

Abstract: The present invention is directed to a fatty acid amide of an amino acid, including a stereoisomer and a salt thereof for use in the treatment of a patient suffering from any type of addiction disorder, substance abuse disorder, including any condition and symptom associated therewith and including withdrawal syndrome and relapse addiction during and after a rehabilitation treatment of said patient.

Abstract: Toughened polyolefins and methods used to produce toughened polyolefins in presence of a bio-filler. These materials can substitute traditional thermoplastic polyolefins known as TPOs or mineral filled TPOs. Exemplary compositions include a phase based on ?-olefin elastomers and the use of biobased fillers. The bio-based filler used, can be a material rich in elemental carbon content. The use of additives is of regular usage for these compositions as they may be related to coupling agents, UV absorbers, light stabilizers, antioxidants, and so forth. These composition offer a remarkable lower density compared to traditional TPOs compositions altogether with bio-based value-performance addition.

Abstract: Biocarbon is presented as an alternative to synthetic carbon black. Master batches having biocarbon for usage in raw plastics and/or the production of composites. Biocarbon is mainly derived from plant biomass, but other sources can be used. A method of producing the master batch: (a) pyrolyzing processed biomass in an oxygen-starved environment to produced biocarbon; (b) comminuting the biocarbon in a reduced oxygen atmosphere; (c) cooling the comminuted biocarbon; (d) mixing the cooled comminuted biocarbon with a carrier resin, thereby producing the master batch.

Abstract: The invention relates to a method of preparing sub-micron biocarbon materials using biomass that is chemically modified with organic or inorganic agents including but not limited to acrylamide, glycine, urea, glycerol, bio-glycerol, corn syrup, succinic acid, and sodium bicarbonate. The use of foaming and heating methodologies which could be either pre or post carbonization and subsequent particle size reduction methodologies for the creation of cost-competitive sub-micron biocarbon particles and fibers for a variety of applications.

Abstract: It is provided a composition for controlled-release of volatile compounds comprising at least one poly(ethylene glycol) (PEG) polymer and one or more volatile compounds, the composition used for preserving food when incorporated in a food packaging. The volatile compounds are antimicrobial compounds such as allyl isothiocyanate (AITC), diacetyl, cinnamaldehyde, thymol, carvacrol and a combination thereof. The composition can comprise a blend of two or more PEG polymers of different molecular weights and/or a mixture of poly(lactic acid) (PLA) and poly(ethylene oxide) (PEO).

Abstract: The invention features thrombospondin-1 (TSP-1) polypeptides (e.g., 3TSR-Fc fusion proteins), nucleic acid molecules encoding the TSP-1 polypeptides, and compositions thereof. The invention also features methods of making and using the TSP-1 polypeptides of the invention (e.g., using 3TSR-Fc fusion proteins to treat a subject having a disorder associated with pathological angiogenesis, e.g., cancer, e.g., epithelial ovarian cancer (EOC)).

Abstract: The present application relates to novel soilless pre-vegetated mats comprising a carrier mat comprised of a material that does not degrade under exterior growing conditions, and vegetation whose roots intertwine within and under the carrier mat. The present application also relates to processes for production of the soilless pre-vegetated mats.

Abstract: The present disclosure describes the identification of single nucleotide polymorphisms (SNPs) in inflammatory diseases and uses thereof, and methods of screening for, diagnosing, identifying susceptibility to or detecting a risk of developing an inflammatory disease comprising detecting the presence or absence of at least one SNP identified in a gene associated with inflammatory disease.

Abstract: Described are methods and products useful for identifying subjects with Mycobacterium avium subspecies paratuberculosis (MAP). A number of protein antigens secreted into culture filtrate by MAP are identified and binding proteins selective for these antigens are demonstrated to be useful for detecting subjects with MAP infections including subjects with Johne's disease.

Abstract: A media supplement for culturing anaerobic bacteria is provided which comprises a filtrate of effluent from a chemostat vessel in which a target bacterial ecosystem has been cultured. Methods of using the supplement for culturing or isolating anaerobic microbial strains or communities, particularly anaerobic bacteria from the human gut, are also provided.

Abstract: A green roofing substrate brick comprises a water-permeable fabric box having an open top, and a solidified and non-compressed substrate in the box. The substrate comprises a water storage and drainage medium, and a binder solidifying the water storage and drainage medium.

Abstract: An Enterobacter species isolated from finger millet, characterized by 16S rRNA gene analysis and the identification of genes that prevent or inhibit the growth of fungal plant pathogens, is disclosed for use with agricultural plants.

Abstract: The present application relates to methods for the reduction of halogenated hydrocarbons using compounds of Formula (I): wherein the reduction of the halogenated compounds is carried out, for example, under ambient conditions without the need for a transition metal containing co-factor. The present application also relates to methods of recovering precious metals using compounds of Formula (I) that are absorbed onto a support material.

Abstract: The present disclosure relates to novel pore-forming toxins of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease.

Abstract: The present disclosure relates to a novel toxin of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease in mammals.

Abstract: The present invention relates to synthetic lung surfactant compositions that contain one or more of phospholipase-resistant phospho-glycerol derivatives, phospholipase-resistant phospho-choline derivatives, and surface active proteins or peptides, more preferably a combination of at least two or all three of these materials. Novel phospholipase-resistant phospho-glycerol derivatives, phospholipase-resistant phospho-choline derivatives, and surface active peptides are also disclosed herein. Uses of the surfactant compositions of the present invention to treat endogenous surfactant dysfunctional or deficient lung tissue, to prepare synthetic peptides for use in the surfactant compositions, and to deliver therapeutic agents are also disclosed.

Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.

Abstract: A composition comprising an isolated fowl adenovirus (FAdV), wherein the FAdV is a strain selected from FAdV-2, FAdV-7, FAdv-8a, FAdV-8b, FAdV-8a/8b or FAdV-11 serotype strains; and a suitable carrier and methods for inducing protective immunity in a subject and/or its progeny.